We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · December 11, 2020

Clinical, Laboratory, and Interferon-α Response Characteristics of Patients With Chilblain-Like Lesions During the COVID-19 Pandemic

JAMA Dermatology

 

Additional Info

JAMA Dermatology
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-Like Lesions During the COVID-19 Pandemic
JAMA Dermatol 2020 Nov 25;[EPub Ahead of Print], T Hubiche, N Cardot-Leccia, F Le Duff, B Seitz-Polski, P Giordana, C Chiaverini, V Giordanengo, G Gonfrier, V Raimondi, O Bausset, Z Adjtoutah, M Garnier, F Burel-Vandenbos, B Dadone-Montaudié, V Fassbender, A Palladini, J Courjon, V Mondain, J Contenti, J Dellamonica, G Leftheriotis, T Passeron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading